KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Labcorp Holdings (LH) Non-Current Assets (2016 - 2025)

Labcorp Holdings' Non-Current Assets history spans 17 years, with the latest figure at $14.4 billion for Q4 2025.

  • For Q4 2025, Non-Current Assets rose 5.89% year-over-year to $14.4 billion; the TTM value through Dec 2025 reached $36.8 billion, up 100.84%, while the annual FY2025 figure was $14.4 billion, 5.89% up from the prior year.
  • Non-Current Assets for Q4 2025 was $14.4 billion at Labcorp Holdings, up from $13.8 billion in the prior quarter.
  • Across five years, Non-Current Assets topped out at $15.5 billion in Q4 2022 and bottomed at -$5.6 billion in Q1 2021.
  • The 5-year median for Non-Current Assets is $13.1 billion (2024), against an average of $8.2 billion.
  • The largest annual shift saw Non-Current Assets tumbled 139.13% in 2021 before it soared 499.66% in 2025.
  • A 5-year view of Non-Current Assets shows it stood at $15.1 billion in 2021, then increased by 3.16% to $15.5 billion in 2022, then decreased by 16.55% to $13.0 billion in 2023, then rose by 4.73% to $13.6 billion in 2024, then increased by 5.89% to $14.4 billion in 2025.
  • Per Business Quant, the three most recent readings for LH's Non-Current Assets are $14.4 billion (Q4 2025), $13.8 billion (Q1 2025), and $13.6 billion (Q4 2024).